Skip to main content
. 2022 Dec 1;49(4):177–189.

Table 2.

Percent of Survival Records Missing Cause of Death (Maximum and Mean) and Survival Statistics for 34 US Registries with < 3% Missing/Unknown Cause-Specific Cause of Death by Primary Site for Diagnosis Years 2011-2017

Primary site at diagnosis Max Mean Survival, n Cause spec censored Cause spec exclude Cause spec dead Diff censored exclude Diff censored dead Diff exclude dead
All sites 2.4 1.1 7,048,111 67.0 66.9 66.7 0.0 0.3 0.3
Oral cavity and pharynx 2.8 0.8 199,700 67.9 67.9 67.6 0.0 0.3 0.3
Esophagus 4.5 1.7 77,217 23.3 23.2 23.1 0.1 0.2 0.2
Stomach 5.1 1.5 106,817 35.6 35.4 35.1 0.2 0.6 0.4
Colon and rectum 2.8 1.2 632,661 64.7 64.7 64.4 0.1 0.3 0.3
Liver and intrahepatic bile duct 5.4 1.5 145,021 23.4 23.2 22.9 0.2 0.5 0.3
Pancreas 1.8 0.6 209,139 12.1 12.0 11.9 0.1 0.2 0.1
Larynx 9.1 1.7 57,895 65.7 65.7 65.4 0.1 0.3 0.3
Lung and bronchus 3.3 1.2 959,490 26.2 26.1 25.9 0.1 0.3 0.2
Melanoma of the skin 4.6 1.2 351,506 89.6 89.6 89.5 0.0 0.1 0.1
Breast 3.5 1.2 1,078,023 88.6 88.5 88.4 0.0 0.2 0.2
Cervix uteri 2.9 1.2 60,254 68.6 68.5 68.1 0.1 0.4 0.4
Corpus and uterus, NOS 1.9 0.7 240,459 81.0 81.0 80.8 0.0 0.2 0.2
Ovary 4.6 1.7 96,486 49.4 49.4 49.1 0.1 0.3 0.2
Prostate 2.9 0.5 895,181 92.7 92.7 92.5 0.0 0.2 0.2
Testis 3.8 1.2 40,157 95.3 95.3 95.3 0.0 0.1 0.1
Urinary bladder 2.8 1.2 329,458 77.2 77.2 76.9 0.0 0.3 0.2
Kidney and renal pelvis 2.8 1.2 275,887 77.5 77.5 77.2 0.0 0.3 0.2
Brain and other nervous system 4.3 0.9 92,316 27.7 27.6 27.3 0.1 0.3 0.2
Thyroid 1.8 0.7 213,979 97.1 97.1 97.0 0.0 0.1 0.1
Hodgkin lymphoma 5.6 2.7 38,400 87.2 87.2 87.0 0.0 0.2 0.2
Non-Hodgkin lymphoma 3.0 1.0 315,332 72.5 72.5 72.2 0.0 0.3 0.3
Myeloma 12.5 2.1 114,643 59.7 59.6 59.3 0.1 0.3 0.3
Leukemia 12.8 3.7 219,241 61.1 61.0 60.7 0.1 0.3 0.3
Mesothelioma 3.4 1.4 14,752 12.1 12.0 11.9 0.1 0.2 0.1

Max, maximum; NOS, not otherwise specified; spec, specific.